Src inhibition modulates AMBRA1‐mediated mitophagy to counteract endothelial‐to‐mesenchymal transition in renal allograft fibrosis

Documenti analoghi

• Targeting Hsp90α to inhibit HMGB1‐mediated renal inflammation and fibrosis
  di: Huizhi Wei, et al.
  Pubblicazione: (2024)
• Single‐cell atlas of healthy vocal folds and cellular function in the endothelial‐to‐mesenchymal transition
  di: Danling Liu, et al.
  Pubblicazione: (2024)
• Exosomes on the development and progression of renal fibrosis
  di: Peihan Wang, et al.
  Pubblicazione: (2024)
• Terazosin, a repurposed GPR119 agonist, ameliorates mitophagy and β‐cell function in NAFPD by inhibiting MST1‐Foxo3a signalling pathway
  di: Chenglei Zhang, et al.
  Pubblicazione: (2024)
• miR615‐3p inhibited FBLN1 and osteogenic differentiation of umbilical cord mesenchymal stem cells by associated with YTHDF2 in a m6A‐miRNA interaction manner
  di: Haoqing Yang, et al.
  Pubblicazione: (2024)